Copy number variation contributes substantially to human evolution, normal phenotypic variation, and human disease (Malhotra and Sebat, 2012). To date, thousands of different genomic duplications and deletions, each spanning hundreds to millions of basepairs, have been mapped genome-wide, and collectively account for a significant fraction of human genetic variation. By reorganizing broad swaths of DNA, structural mutations potentially create new genes and regulatory motifs while also disrupting established genes.
Copy number variants (CNVs) tend to occur in regions rich in genes, segmental duplications, and mobile elements(Malhotra and Sebat, 2012). Some arise repeatedly as de novo mutations in genomic ‘hotspots.’ The genomic architecture of hotspots is typically characterized by large repeated segments that increase the risk for errors in replication, a process known as nonallelic homologous recombination. If a CNV is pathogenic, it may persist for only a few generations given negative selection. At the same time, in each generation many de novo CNVs are introduced given the highly repetitive nature of the human genome.
The importance of rare copy number mutations for neuropsychiatric disease is now well-established (Malhotra and Sebat, 2012). Our group was the first to demonstrate that individuals with schizophrenia are significantly more likely than unaffected persons to harbor rare gene-impacting CNVs, with greater effect for patients with illness onset before age 18 years. Genes disrupted by CNVs in patients function disproportionately in signaling and neurodevelopmental processes, including neuregulin and glutamate pathways (Walsh et al, 2008). Subsequent research replicated and extended these findings. Most rare copy number mutations implicated in schizophrenia are unique, and many arose de novo or in recent generations. Others recur at genomic hotspots, including chromosomes 1q21.1, 3q29, 15q11.2, 15q13.3, 16p11.2, 16p12.1, 16p13.11, 17p12, 22q11.2, and the neuropeptide receptor VIPR2 (Malhotra and Sebat, 2012) (Figure 1).
One novel mechanism by which CNVs may cause schizophrenia is the creation of chimeric genes (Rippey et al, 2013). We recently found that persons with schizophrenia were more likely than controls to carry genomic duplications or deletions that resulted in a fusion gene. Each of the chimeric genes in patients differed from their parent genes in ways likely to be important to brain function, including differences in neuronal subcellular localization, levels of expression, and/or protein interactions. For example, one patient harbored a 150-kb deletion that resulted in a MAP3K3–DDX42 fusion gene. The MAP3K3–DDX42 chimera produced a novel protein isoform that binds activated MEK5 and likely acts as a dominant-negative inhibitor of ERK5 signaling, a key pathway regulating neuronal differentiation and adult neurogenesis. By interfering with parent gene function, chimeras potentially disrupt critical brain processes important to schizophrenia.
Rare deletions and duplications, including in the same recurrent hotspot CNVs associated with schizophrenia, are also enriched in other neuropsychiatric conditions, including autism, intellectual disability, and idiopathic generalized epilepsy (Malhotra and Sebat, 2012). Many clinical laboratories now have assays that can detect hundreds of potentially pathogenic CNVs. Each disorder is associated with many different structural mutations. Each pathogenic CNV is associated with different phenotypes in different persons, including cognitive deficits in individuals characterized as ‘unaffected’ (Stefansson et al, 2014). Variable phenotypic expression of pathogenic events is likely mediated by a variety of different factors, including dose effects, epistasis, epigenetic mechanisms, and environmental exposures (McClellan and King, 2010).
Genes and loci disrupted by pathogenic CNVs provide a window to study key neurobiological mechanisms important to brain development and pathophysiology. For example, rare de novo CNVs in persons with schizophrenia were found to be enriched for genes that function within N-methyl-D-aspartate receptor postsynaptic signaling complexes (Kirov et al, 2012). Given the extreme genetic heterogeneity, such research is critical towards delineating specific genomically defined neurobiological subtypes within large clinically heterogeneous diagnostic groups, and ultimately towards developing biologically informed targeted treatments.
FUNDING AND DISCLOSURE
This work was supported by NIMH grants R01MH083989 and F30MH085467. The authors declare no conflict of interest.
References
Malhotra D, Sebat J (2012). CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 148: 1223–1241.
Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM et al (2008). Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320: 539–543.
Rippey C, Walsh T, Gulsuner S, Brodsky M, Nord AS, Gasperini M et al (2013). Formation of chimeric genes by copy-number variation as a mutational mechanism in schizophrenia. Am J Hum Genet 93: 697–710.
Stefansson H, Meyer-Lindenberg A, Steinberg S, Magnusdottir B, Morgen K, Arnarsdottir S et al (2014). CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 505: 361–366.
McClellan J, King MC (2010). Genetic heterogeneity in human disease. Cell 141: 210–217.
Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D et al (2012). De novo CNV analysis implicates specific abnormalities of postsynaptic signaling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 17: 142–153.
Author information
Authors and Affiliations
Corresponding author
PowerPoint slides
Rights and permissions
About this article
Cite this article
Gulsuner, S., McClellan, J. Copy Number Variation in Schizophrenia. Neuropsychopharmacol 40, 252–254 (2015). https://doi.org/10.1038/npp.2014.216
Published:
Issue Date:
DOI: https://doi.org/10.1038/npp.2014.216
This article is cited by
-
The genetics of bipolar disorder
Molecular Psychiatry (2020)
-
Functional annotation of rare structural variation in the human brain
Nature Communications (2020)
-
Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach
Molecular Neurobiology (2018)